gestational diabetes
…(physical activity based, diet based, or mixed) in pregnancy on gestational diabetes. Main outcomes were gestational diabetes defined by any criteri…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 38 of 2459choroidal melanomaiodine-125Ru106PBRI125brachytherapyruthenium-106Ru 106Ru106patients
…am radiotherapy (PBR) are well established for the treatment of choroidal melanoma. This study aimed to evaluate the rates of local tumour control…
melanomaurothelial carcinomaHNSCCNSCLCRCC
…revolutionized treatment outcomes for advanced cancers, notably melanoma, NSCLC, RCC, urothelial carcinoma, and HNSCC. 1 2 By antagonizi…
pembrolizumabNSCLCnivolumabKEYNOTE-189KEYNOTE-407non-small cell lung canceripilimumabCM9LA
…ipilimumab/chemotherapy), against KEYNOTE-189, and KEYNOTE-407 (pembrolizumab/chemotherapy). We analyzed both the progression free survival (…
durvalumabatezolizumabextensive-stage small cell lung cancerextensive-stage small-cell lung cancerplatinum-etoposidetremelimumabimmunotherapyfirst-line chemotherapyES-SCLC
…otherapy, 563 (87.4%) received atezolizumab; 61 (9.5%) received durvalumab. We found that the median OS was 9 months vs 7.2 months (p <0.0…
NivolumabBiliary tract canceripilimumabPembrolizumabgemcitabineGranzyme BcisplatinBTC
…ansen JS, Larsen FO, Theile S, Hasselby JP, Willemoe GL, et al. Nivolumab with or without ipilimumab combined with stereotactic body radi…
melanomacervical cancerKSQ-004EXNSCLCpancreatic cancerIL-2CRCcolorectal carcinomanon-small cell lung cancerHNSCC
…EX in patients with select advanced solid tumors. Patients with melanoma, NSCLC, HNSCC, CRC, pancreatic, and cervical cancer who have pr…
melanomaBrown University HealthipilimumabnivolumabBrain metastasesadvanced melanomaLifespan- Rhode Island Hospital Institutional Review BoardsurgeryICI
…ll DP, Sullivan R, Brastianos PK. Upfront surgical resection of melanoma brain metastases provides a bridge toward immunotherapy-mediate…
99.1%
melanomahuman colorectal cancerADU-S100Chris Sullivan Fund
…K GES score using the TCGA PanCancer Atlas. Using Yumm1.7 mouse melanoma models in STING-deficient hosts, we evaluated TLS formation fol…
AldesleukinAZD6750IL-2
…index of IL-2 by maintaining the superior potency attributed to Aldesleukin treatment without compromising on the improved safety (as measu…
AdalimumabRituximabprednisoloneNintedanibMethotrexaterheumatoid arthritisSulfasalazineRA-ILDpulmonary fibrosisIPF
…otrexate and Sulfasalazine as well as biological agents such as Adalimumab and Rituximab. Here, we therefore compare real-world experience…
AECOPDchronic obstructive pulmonary diseaseCOPDPulmonary rehabilitationPRCOPDConclusionsPR
…dividuals included in the PR audit were referred to PR after an AECOPD managed in secondary care, of which 69% (n=685) were enrolled. …